Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis.
about
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Long-term use of adalimumab as ...... nts with rheumatoid arthritis.
@en
Long-term use of adalimumab as ...... nts with rheumatoid arthritis.
@nl
type
label
Long-term use of adalimumab as ...... nts with rheumatoid arthritis.
@en
Long-term use of adalimumab as ...... nts with rheumatoid arthritis.
@nl
prefLabel
Long-term use of adalimumab as ...... nts with rheumatoid arthritis.
@en
Long-term use of adalimumab as ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P1433
P1476
Long-term use of adalimumab as ...... nts with rheumatoid arthritis.
@en
P2093
Edward C Keystone
Ferdinand C Breedveld
Hartmut Kupper
Iain Sainsbury
Stefan Florentinus
P2860
P304
P356
10.1136/RMDOPEN-2017-000637
P577
2018-06-13T00:00:00Z